ARISTO PHARMA LIMITED

Active
Company number 09225220Private limited companyIncorporated 2014

Key figures

£338,131+56.8%
Net assets 2025
+59.8%
Average annual growth 2020–2025
0100 k200 k300 k400 k20202021202220232025

Like most small UK companies, ARISTO PHARMA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025

Sector comparison

SIC 74909

Where the company stands among the 58,503 active companies whose first SIC code is 74909 (Other professional, scientific and technical activities n.e.c.).

Net assets£338,131
Higher than 90% · median £12,925
Total assets£762,038
Higher than 91% · median £41,823
Cash£212,286
Higher than 81% · median £26,310
Employees0
Lower than 75% · median 1
Company age12.1 years
Older than 62% · median 9.4 years
Largest in this sector by net assets
  1. KINTAIL TRUSTEES LIMITED£1.1bn
  2. VERTIV COMPANY GROUP LIMITED£853.3m
  3. NUCLEUS FINANCIAL PLATFORMS LIMITED£665.1m
  4. CHIVAS BROTHERS INTERNATIONAL LIMITED£645m
  5. JANE'S GROUP UK LIMITED£566.4m
  6. LEARNING TECHNOLOGIES GROUP LIMITED£477.9m
  7. ALMAC CLINICAL SERVICES LIMITED£477m
  8. TOWERS WATSON LIMITED£444.5m
  9. MAGI CAPITAL CREDIT LTD£399.9m
  10. NCC GROUP PLC£332.6m

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 58,503. The line on each bar marks the median.

Summary: ARISTO PHARMA LIMITED

What kind of company is it?

ARISTO PHARMA LIMITED is a private limited company registered with Companies House under company number 09225220. It was incorporated on 18 Sep 2014. Its status is active. The registered office is in Ely (CB6). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

How is the company doing financially?

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts. Net assets were £338,131, up 56.8% on the previous year. Cash at bank and in hand was £212,286. Total assets were £762,038 and total liabilities £423,907. The company had an average of 0 employees. Figures are available for 5 financial years (2020–2025).

How does it compare with similar companies?

Compared with 58,503 active companies whose first SIC code is 74909: By net assets it ranks higher than 90% of them (median £12,925). By total assets it ranks higher than 91% of them (median £41,823). By cash it ranks higher than 81% of them (median £26,310). By number of employees it ranks lower than 75% of them (median 1). It is older than 62% of them (median age 9.4 years).

Does it supply the public sector?

The company is named as a supplier in 8 public contract award notices from 4 public sector buyers since 2021. Contracts awarded to it alone have a combined published value of £38.3k. Its most frequent buyer is NHS England (3 contracts). 3 of the awards are shared with other suppliers, typically framework agreements.

Who runs and controls the company?

The company has 3 current directors. One person with significant control is registered.

When are its next filings due?

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 14 Jul 2027.

Filed accounts2020–2025
20202021202220232025
Profit for the year38,25650,36551,91161,456—
Cash at bank and in hand99,074176,209334,040361,969212,286
Total assets344,761355,539542,996560,811762,038
Total liabilities295,092254,840390,652346,485423,907
Net assets / total equity51,847102,212154,123215,579338,131
Average number of employees33340

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Public contracts

8 contracts

ARISTO PHARMA LIMITED is named as a supplier in 8 public contract award notices from 4 public sector buyers since 2021. The 2 contracts awarded to it alone with a published value add up to £38.3k. 3 awards are shared with other suppliers and not counted in that total.

Contracts per year
Main buyers4
NHS England
3 contracts
Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on beha…
2 contracts · £38.3k
ATAMIS LTD
2 contracts
The NHS Commissioning Board (operating under the name of NHS England)
1 contract
Contracts
  1. NHS National Generic Pharmaceuticals Wave 15a‡NHS England · £1
  2. NHS National Generics Pharmaceuticals Transition 2023_1‡NHS England · £1
  3. NHS National Generic Pharmaceuticals Wave 14a‡NHS England · shared by 99 suppliers, up to £207,982,407 in total
  4. Generic Drugs - Tablets & Capsules‡Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on beha… · £27,026
  5. NHS National Generic Pharmaceuticals Wave 13‡ATAMIS LTD · shared by 100 suppliers, up to £939,483,068 in total · 2 lots
Show 3 more
  1. NHS National Generic Pharmaceuticals Wave 13‡ATAMIS LTD · shared by 99 suppliers, up to £469,741,550 in total
  2. NHS National Generic Pharmaceuticals Wave 13‡The NHS Commissioning Board (operating under the name of NHS England) · £2 · 2 lots
  3. Generic Drugs - Topicals & Miscellaneous‡Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on beha… · £11,256

From contract award notices on Contracts Finder (since 2016) and Find a Tender (since 2021), published by the Cabinet Office under the Open Government Licence v3.0. Values are as published by the buyer and usually cover the whole contract term; the total leaves out awards shared between several suppliers, where the published figure is a ceiling for all of them, placeholder values and single figures of £1 billion or more. Notices marked ‡ do not state a company number and were linked by an exact match on the registered name. Contracts below the publication thresholds and those of devolved buyers that publish elsewhere are not included.

History

21 events
  1. Financial year 2025 endedAccounts: net assets £338.1k, 0 employees
  2. Marian KOMAR appointedDirector
  3. John Hudson KRIWET appointedDirector
  4. Kenneth Lawrie WILLIAMSON resignedDirector
  5. John Haydn Francis FLETCHER resignedDirector
  6. Financial year 2023 endedAccounts: net assets £215.6k, 4 employees
  7. Financial year 2022 endedAccounts: net assets £154.1k, 3 employees
  8. Financial year 2021 endedAccounts: net assets £102.2k, 3 employees
Earlier events (13)
  1. Ian Alan CHATTERTON appointedDirector
  2. Financial year 2020 endedAccounts: net assets £51.8k, 3 employees
  3. Name changed to ARISTO PHARMA LIMITEDPreviously CEB PHARMA LIMITED
  4. Ian Alan CHATTERTON resignedDirector
  5. John COATES resignedDirector
  6. Chandrakant Vallabhdas ONDHIA resignedDirector
  7. Aristo Pharma Gmbh registered as a person with significant control
  8. Ian Alan CHATTERTON appointedDirector
  9. John COATES appointedDirector
  10. John Haydn Francis FLETCHER appointedDirector
  11. Chandrakant Vallabhdas ONDHIA appointedDirector
  12. Kenneth Lawrie WILLIAMSON appointedDirector
  13. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.